SCHEMBL13775020

SCHEMBL13775020

CC(=O)OCC1OC(OCC2OC(OCc3ccccc3)C(OC3OC(COC(C)=O)C(OC(C)=O)C(OC(C)=O)C3C)C(OC(C)=O)C2OC(C)=O)C(C)C(OC(C)=O)C1OC(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.53
▸ LMNA P02545 2/20 0.52
▸ CYP2D6 P10635 2/20 0.51
▸ POLB P06746 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ KMT2A Q03164 1/20 0.50
▸ PAX8 Q06710 1/20 0.45
▸ PRKCA P17252 1/20 0.45
▸ AKT1 P31749 1/20 0.45
▸ PTK2 Q05397 1/20 0.45
▸ CA9 Q16790 4/20 0.45
▸ CA2 P00918 4/20 0.45
▸ CA1 P00915 3/20 0.45
▸ FGF1 P05230 2/20 0.45
▸ FGF2 P09038 2/20 0.45
▸ VEGFA P15692 2/20 0.45
▸ HPSE Q9Y251 2/20 0.45
▸ THRB P10828 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12920544 0.89 TSHR (0.58) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL23742930 0.88 TSHR (0.64) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL8722654 0.88 TSHR (0.64) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL15514610 0.88 TSHR (0.64) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL8722653 0.88 TSHR (0.64) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL10359936 0.88 TSHR (0.64) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL1582789 0.87 CYP2D6 (0.54) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL14409792 0.87 CYP2D6 (0.54) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL6859193 0.86 LMNA (0.62) TSHRLMNACYP2D6POLBALDH1A1
SCHEMBL6867867 0.86 LMNA (0.62) TSHRLMNACYP2D6POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176970-A1 Preparation of Thiosugars and Their Use GLYCOFORM LIMITED (GB) 2009-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176970-A1 Preparation of Thiosugars and Their Use TST, TREH, FUT6 TSHR 1206/4885LMNA 3594/4885CYP2D6 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback